Acadia Healthcare (ACHC) vs Clover Health Investments (CLOV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Clover Health Investments (CLOV) has outperformed Acadia Healthcare (ACHC) over the past year, gaining 68.9% versus a gain of 7.3%. Over five years, CLOV leads with a -42.4% price change compared with -48.6% for ACHC. Acadia Healthcare is the larger company by market cap ($2.72 billion vs $2.42 billion), about 1.1 times the size, while Clover Health Investments is growing revenue faster (+40.3% vs +5.0%).
On valuation, Acadia Healthcare trades at a lower forward P/E (15.8x vs 30.4x for Clover Health Investments). Clover Health Investments converts more of its revenue into profit, with a net margin of -4.4% versus -33.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACHC | CLOV |
|---|---|---|
| Share price | $29.23 | $4.56 |
| Market cap | $2.72B | $2.42B |
| 1-day change | +0.65% | -0.87% |
| YTD return | +105.99% | +94.04% |
| 1-year return | +7.34% | +68.89% |
| 5-year return | -48.62% | -42.35% |
| Forward P/E | 15.83 | 30.40 |
| EPS (TTM) | $-12.50 | $-0.05 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $3.31B | $1.92B |
| Revenue growth (YoY) | +5.04% | +40.34% |
| Net income (latest FY) | $-1.10B | $-85.55M |
| Operating margin | — | -4.44% |
| Net margin | -33.29% | -4.45% |
| 52-week high | $35.83 | $5.59 |
| 52-week low | $11.43 | $1.58 |
| Distance from 52-week high | -18.42% | -18.43% |
| Analyst consensus | buy | none |
| Avg. price target upside | +15.60% | +17.98% |
| Average volume | 2.04M | 4.27M |
| Shares outstanding | 93.10M | 435.44M |
| Employees | 25,000 | 724 |
| Sector | Health Care | Healthcare |
| Industry | Medical Specialities | Healthcare Plans |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CLOV has outperformed ACHC by 61.5 percentage points over the past year.
- Clover Health Investments is more profitable, keeping -4.4 cents of every revenue dollar as net income versus -33.3 cents for Acadia Healthcare.
- Clover Health Investments grew revenue faster in its latest fiscal year (+40.34% vs +5.04%).
- The two companies sit in different sectors: Acadia Healthcare in Health Care and Clover Health Investments in Healthcare.
About Acadia Healthcare
ACHC stock →Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico.
Health Care · Medical Specialities · 25,000 employees
About Clover Health Investments
CLOV stock →Clover Health Investments, Corp. provides medicare advantage plans in the United States.
Healthcare · Healthcare Plans · 724 employees
ACHC vs CLOV FAQ
Which is bigger, Acadia Healthcare or Clover Health Investments?
Acadia Healthcare (ACHC) is larger, with a market capitalization of $2.72B compared with $2.42B for Clover Health Investments (CLOV).
Which stock has performed better over the past year, ACHC or CLOV?
CLOV returned +68.89% over the past 12 months, compared with +7.34% for ACHC (price return, excluding dividends). Past performance does not predict future results.
Are Acadia Healthcare and Clover Health Investments in the same industry?
No. Acadia Healthcare is in the Health Care sector, while Clover Health Investments is in Healthcare.